Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wiltschke

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activityC Wiltschke, M Krainer, M Nanut, et al.
Neoplasma|January 1, 1992
Cytokine (IFN-alpha, IFN-gamma, IL-1-alpha, TNF-alpha)-induced modulation of HLA cell surface expression in human breast cancer cell linesJ Sedlák, P Speiser, R Zeillinger, et al.
Thrombosis Research|May 11, 2016
PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patientsO Königsbrügge, J Riedl, E Grilz, et al.
Immunobiology|June 1, 1989
Murine recombinant GM-CSF-driven rat bone marrow cell differentiation and factors suppressing cell proliferationC Wiltschke, H Nemet, C Holzinger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Anti-HER-2/neu antibodies detected in sera of patients with breast cancer, but also in healthy femalesJ Jasinska, C Wiltschke, T Brodowicz, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patientsC Wiltschke, I Kindas-Muegge, A Steininger, et al.
Wiener Klinische Wochenschrift|January 1, 1995
[The significance of adhesion molecules in oncology]A C Budinsky, C Wiltschke, T Brodowicz, et al.
International Journal of Cancer|June 11, 1997
Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitroA C Budinsky, T Brodowicz, C Wiltschke, et al.
International Journal of Cancer|December 17, 1997
Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitroT Brodowicz, C Wiltschke, A C Budinsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Expression of a binding structure for sialic acid-containing glycoconjugates on rat bone marrow-derived macrophages and its modulation by IFN, TNF-alpha, and dexamethasoneA Gessl, G Boltz-Nitulescu, C Wiltschke, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activityC Wiltschke, M Krainer, M Nanut, et al.
Neoplasma|January 1, 1992
Cytokine (IFN-alpha, IFN-gamma, IL-1-alpha, TNF-alpha)-induced modulation of HLA cell surface expression in human breast cancer cell linesJ Sedlák, P Speiser, R Zeillinger, et al.
Thrombosis Research|May 11, 2016
PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patientsO Königsbrügge, J Riedl, E Grilz, et al.
Immunobiology|June 1, 1989
Murine recombinant GM-CSF-driven rat bone marrow cell differentiation and factors suppressing cell proliferationC Wiltschke, H Nemet, C Holzinger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Anti-HER-2/neu antibodies detected in sera of patients with breast cancer, but also in healthy femalesJ Jasinska, C Wiltschke, T Brodowicz, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patientsC Wiltschke, I Kindas-Muegge, A Steininger, et al.
Wiener Klinische Wochenschrift|January 1, 1995
[The significance of adhesion molecules in oncology]A C Budinsky, C Wiltschke, T Brodowicz, et al.
International Journal of Cancer|June 11, 1997
Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitroA C Budinsky, T Brodowicz, C Wiltschke, et al.
International Journal of Cancer|December 17, 1997
Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitroT Brodowicz, C Wiltschke, A C Budinsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Expression of a binding structure for sialic acid-containing glycoconjugates on rat bone marrow-derived macrophages and its modulation by IFN, TNF-alpha, and dexamethasoneA Gessl, G Boltz-Nitulescu, C Wiltschke, et al.
Pageof 6